Literature DB >> 34077698

Reduced Proportion and Activity of Natural Killer Cells in the Lung of Patients with Idiopathic Pulmonary Fibrosis.

Tamara Cruz1, Minxue Jia1,2, John Sembrat1, Tracy Tabib1, Naomi Agostino1, Tullia C Bruno1, Dario Vignali1, Pablo Sanchez1, Robert Lafyatis1, Ana L Mora1, Panayiotis Benos1,2, Mauricio Rojas1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34077698      PMCID： PMC8491266          DOI： 10.1164/rccm.202012-4418LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   30.528


× No keyword cloud information.
  10 in total

1.  Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis.

Authors:  Christina Morse; Tracy Tabib; John Sembrat; Kristina L Buschur; Humberto Trejo Bittar; Eleanor Valenzi; Yale Jiang; Daniel J Kass; Kevin Gibson; Wei Chen; Ana Mora; Panayiotis V Benos; Mauricio Rojas; Robert Lafyatis
Journal:  Eur Respir J       Date:  2019-08-22       Impact factor: 16.671

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 3.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

4.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

Authors:  Tae-Won Kang; Tetyana Yevsa; Norman Woller; Lisa Hoenicke; Torsten Wuestefeld; Daniel Dauch; Anja Hohmeyer; Marcus Gereke; Ramona Rudalska; Anna Potapova; Marcus Iken; Mihael Vucur; Siegfried Weiss; Mathias Heikenwalder; Sadaf Khan; Jesus Gil; Dunja Bruder; Michael Manns; Peter Schirmacher; Frank Tacke; Michael Ott; Tom Luedde; Thomas Longerich; Stefan Kubicka; Lars Zender
Journal:  Nature       Date:  2011-11-09       Impact factor: 49.962

Review 5.  Metallothionein and the biology of aging.

Authors:  William R Swindell
Journal:  Ageing Res Rev       Date:  2010-10-08       Impact factor: 10.895

6.  Comprehensive Profiling of an Aging Immune System Reveals Clonal GZMK+ CD8+ T Cells as Conserved Hallmark of Inflammaging.

Authors:  Denis A Mogilenko; Oleg Shpynov; Prabhakar Sairam Andhey; Laura Arthur; Amanda Swain; Ekaterina Esaulova; Simone Brioschi; Irina Shchukina; Martina Kerndl; Monika Bambouskova; Zhangting Yao; Anwesha Laha; Konstantin Zaitsev; Samantha Burdess; Susan Gillfilan; Sheila A Stewart; Marco Colonna; Maxim N Artyomov
Journal:  Immunity       Date:  2020-11-21       Impact factor: 31.745

7.  Cellular senescence mediates fibrotic pulmonary disease.

Authors:  Marissa J Schafer; Thomas A White; Koji Iijima; Andrew J Haak; Giovanni Ligresti; Elizabeth J Atkinson; Ann L Oberg; Jodie Birch; Hanna Salmonowicz; Yi Zhu; Daniel L Mazula; Robert W Brooks; Heike Fuhrmann-Stroissnigg; Tamar Pirtskhalava; Y S Prakash; Tamara Tchkonia; Paul D Robbins; Marie Christine Aubry; João F Passos; James L Kirkland; Daniel J Tschumperlin; Hirohito Kita; Nathan K LeBrasseur
Journal:  Nat Commun       Date:  2017-02-23       Impact factor: 14.919

8.  The IL-15-AKT-XBP1s signaling pathway contributes to effector functions and survival in human NK cells.

Authors:  Yufeng Wang; Yibo Zhang; Ping Yi; Wenjuan Dong; Ansel P Nalin; Jianying Zhang; Zheng Zhu; Lichao Chen; Don M Benson; Bethany L Mundy-Bosse; Aharon G Freud; Michael A Caligiuri; Jianhua Yu
Journal:  Nat Immunol       Date:  2018-12-10       Impact factor: 25.606

9.  Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Tamara Cruz; Alejandra López-Giraldo; Guillaume Noell; Sandra Casas-Recasens; Tamara Garcia; Laureano Molins; Manel Juan; Marco A Fernandez; Alvar Agustí; Rosa Faner
Journal:  Respir Res       Date:  2019-07-12

10.  The impact of ageing on natural killer cell function and potential consequences for health in older adults.

Authors:  Jon Hazeldine; Janet M Lord
Journal:  Ageing Res Rev       Date:  2013-05-06       Impact factor: 10.895
  10 in total
  3 in total

1.  Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes.

Authors:  Jiafeng Zheng; Hanquan Dong; Tongqiang Zhang; Jing Ning; Yongsheng Xu; Chunquan Cai
Journal:  Front Genet       Date:  2022-04-26       Impact factor: 4.772

2.  A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis.

Authors:  Run Guo; Yuefei Zhou; Fang Lin; Mengxing Li; Chunting Tan; Bo Xu
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

Review 3.  Stem cells, cell therapies, and bioengineering in lung biology and disease 2021.

Authors:  Laertis Ikonomou; Mattias Magnusson; Ruben Dries; Erica L Herzog; Robert E Hynds; Zea Borok; Jin-Ah Park; Steven Skolasinski; Janette K Burgess; Leigh Turner; Sarah M Mojarad; John E Mahoney; Thomas Lynch; Mareike Lehmann; Victor J Thannickal; Jamie L Hook; Andrew E Vaughan; Evan T Hoffman; Daniel J Weiss; Amy L Ryan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-06-28       Impact factor: 6.011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.